Pharmaceutical
Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Cosmetic Raw Material
OEM & ODM
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales28@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Rivaroxaban Raw Material Baclofen Powder
Product Overview:
High Quality Rivaroxaban Powder Raw Material CAS 366789-02-8, Rivaroxaban Raw Powder China Rivaroxaban Manufacturer Supply, 99% Purity Rivaroxaban Raw Powder, Factory Supply Rivaroxaban Raw Material Pharmaceutical Raw Material Rivaroxaban Raw Powder.
Rivaroxaban Raw Material Baclofen Powder Attributes
CAS: 366789-02-8
MF: C19H18ClN3O5S
MW: 435.88
EINECS: 685-132-2
Specification: 99% min Rivaroxaban
Sample: Rivaroxaban Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance: White Powder
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Rivaroxaban Raw Material Baclofen Powder Details
High Quality Rivaroxaban Powder Raw Material CAS 366789-02-8, Rivaroxaban Raw Powder China Rivaroxaban Manufacturer Supply, 99% Purity Rivaroxaban Raw Powder, Factory Supply Rivaroxaban Raw Material Pharmaceutical Raw Material Rivaroxaban Raw Powder.
Rivaroxaban Raw Materials is a new oral anticoagulant used in adult patients with non-valvular atrial fibrillation (except for atrial fibrillation due to rheumatic heart valve disease, and atrial fibrillation occurring after heart valve replacement) to reduce the risk of stroke and systemic embolism.
Uses and functions of Rivaroxaban Powder
Novel anticoagulants were first used for thromboprophylaxis after orthopedic surgeries, including total hip and knee replacements, and have been reported to be non-inferior to low molecular heparin in terms of effectiveness and safety.
Nowadays, novel anticoagulants are gradually being widely used in the treatment of lower extremity venous thrombosis and pulmonary embolism, and the latest ESC guidelines for the diagnosis and treatment of acute pulmonary embolism in 2014 mentioned that
Novel anticoagulants can be used as an emerging anticoagulant to replace traditional anticoagulant treatments, and they will be gradually promoted in high cardiovascular diseases such as atrial fibrillation and acute coronary syndromes.
Pharmacological Effects of Rivaroxaban Raw Powder
Rivaroxaban Raw Powder is a highly selective and competitive inhibitor of free and bound factor Xa and prothrombin activity, prolonging activated partial thromboplastin time (PT) and aPTT in a dose-dependent manner.
Rivaroxaban Powder is essentially different from sodium sulfadoxine/heparin in that it does not require the involvement of antithrombin III, directly antagonizes free and bound factor Xa to reduce thrombin activation and thus prolongs clotting time, and not only blocks clot formation but also destroys clots that have already formed.
Rivaroxaban Powder helps to prevent the formation and further development of blood clots during hip or knee replacements, where the backflow of blood from the leg veins to the heart is poor and blood clots are easily formed.
Production method of Raw Rivaroxaban Powder